nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—ABCB1—colon cancer	0.395	1	CbGaD
Fluconazole—CYP3A7—Irinotecan—colon cancer	0.0578	0.122	CbGbCtD
Fluconazole—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0578	0.122	CbGbCtD
Fluconazole—CYP3A7—Vincristine—colon cancer	0.0505	0.107	CbGbCtD
Fluconazole—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0505	0.107	CbGbCtD
Fluconazole—CYP2C9—Capecitabine—colon cancer	0.0471	0.0996	CbGbCtD
Fluconazole—CYP3A5—Irinotecan—colon cancer	0.0434	0.0918	CbGbCtD
Fluconazole—CYP3A5—Vincristine—colon cancer	0.0379	0.0802	CbGbCtD
Fluconazole—ABCB1—Irinotecan—colon cancer	0.0282	0.0597	CbGbCtD
Fluconazole—CYP2C9—Fluorouracil—colon cancer	0.0279	0.0591	CbGbCtD
Fluconazole—ABCB1—Vincristine—colon cancer	0.0247	0.0522	CbGbCtD
Fluconazole—CYP3A4—Irinotecan—colon cancer	0.0169	0.0358	CbGbCtD
Fluconazole—ABCB1—Methotrexate—colon cancer	0.0149	0.0316	CbGbCtD
Fluconazole—CYP3A4—Vincristine—colon cancer	0.0148	0.0313	CbGbCtD
Fluconazole—Ataxia—Capecitabine—colon cancer	0.000409	0.00308	CcSEcCtD
Fluconazole—Alopecia—Vincristine—colon cancer	0.000408	0.00308	CcSEcCtD
Fluconazole—Angiopathy—Irinotecan—colon cancer	0.000408	0.00308	CcSEcCtD
Fluconazole—Immune system disorder—Irinotecan—colon cancer	0.000406	0.00306	CcSEcCtD
Fluconazole—Mediastinal disorder—Irinotecan—colon cancer	0.000406	0.00306	CcSEcCtD
Fluconazole—Mental disorder—Vincristine—colon cancer	0.000405	0.00305	CcSEcCtD
Fluconazole—Chills—Irinotecan—colon cancer	0.000404	0.00304	CcSEcCtD
Fluconazole—Urine output increased—Methotrexate—colon cancer	0.000404	0.00304	CcSEcCtD
Fluconazole—Dry skin—Capecitabine—colon cancer	0.000399	0.00301	CcSEcCtD
Fluconazole—Alopecia—Irinotecan—colon cancer	0.000398	0.003	CcSEcCtD
Fluconazole—Hypokalaemia—Capecitabine—colon cancer	0.000396	0.00299	CcSEcCtD
Fluconazole—Breast disorder—Capecitabine—colon cancer	0.000393	0.00296	CcSEcCtD
Fluconazole—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000392	0.00295	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000392	0.00295	CcSEcCtD
Fluconazole—Back pain—Vincristine—colon cancer	0.000389	0.00293	CcSEcCtD
Fluconazole—Sepsis—Methotrexate—colon cancer	0.000387	0.00292	CcSEcCtD
Fluconazole—Flatulence—Irinotecan—colon cancer	0.000386	0.00291	CcSEcCtD
Fluconazole—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000384	0.00289	CcSEcCtD
Fluconazole—Alopecia—Fluorouracil—colon cancer	0.000381	0.00287	CcSEcCtD
Fluconazole—Back pain—Irinotecan—colon cancer	0.000379	0.00286	CcSEcCtD
Fluconazole—Anaemia—Vincristine—colon cancer	0.000372	0.0028	CcSEcCtD
Fluconazole—Agitation—Vincristine—colon cancer	0.00037	0.00279	CcSEcCtD
Fluconazole—Polyuria—Methotrexate—colon cancer	0.000369	0.00278	CcSEcCtD
Fluconazole—Sweating increased—Capecitabine—colon cancer	0.000367	0.00276	CcSEcCtD
Fluconazole—Ill-defined disorder—Irinotecan—colon cancer	0.000363	0.00274	CcSEcCtD
Fluconazole—Anaemia—Irinotecan—colon cancer	0.000362	0.00273	CcSEcCtD
Fluconazole—Vertigo—Vincristine—colon cancer	0.000361	0.00272	CcSEcCtD
Fluconazole—Hepatic failure—Methotrexate—colon cancer	0.000361	0.00272	CcSEcCtD
Fluconazole—Leukopenia—Vincristine—colon cancer	0.00036	0.00271	CcSEcCtD
Fluconazole—Malaise—Irinotecan—colon cancer	0.000353	0.00266	CcSEcCtD
Fluconazole—Vertigo—Irinotecan—colon cancer	0.000352	0.00265	CcSEcCtD
Fluconazole—Neutropenia—Capecitabine—colon cancer	0.000352	0.00265	CcSEcCtD
Fluconazole—Leukopenia—Irinotecan—colon cancer	0.000351	0.00264	CcSEcCtD
Fluconazole—Convulsion—Vincristine—colon cancer	0.000348	0.00263	CcSEcCtD
Fluconazole—Hypertension—Vincristine—colon cancer	0.000347	0.00262	CcSEcCtD
Fluconazole—Anaemia—Fluorouracil—colon cancer	0.000347	0.00261	CcSEcCtD
Fluconazole—Myalgia—Vincristine—colon cancer	0.000342	0.00258	CcSEcCtD
Fluconazole—Hypertension—Irinotecan—colon cancer	0.000338	0.00255	CcSEcCtD
Fluconazole—Leukopenia—Fluorouracil—colon cancer	0.000336	0.00253	CcSEcCtD
Fluconazole—Infestation NOS—Capecitabine—colon cancer	0.000335	0.00253	CcSEcCtD
Fluconazole—Infestation—Capecitabine—colon cancer	0.000335	0.00253	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000333	0.00251	CcSEcCtD
Fluconazole—Discomfort—Irinotecan—colon cancer	0.000329	0.00248	CcSEcCtD
Fluconazole—Anaphylactic shock—Vincristine—colon cancer	0.000328	0.00247	CcSEcCtD
Fluconazole—Stomatitis—Capecitabine—colon cancer	0.000327	0.00246	CcSEcCtD
Fluconazole—Jaundice—Capecitabine—colon cancer	0.000327	0.00246	CcSEcCtD
Fluconazole—Convulsion—Fluorouracil—colon cancer	0.000325	0.00245	CcSEcCtD
Fluconazole—Nervous system disorder—Vincristine—colon cancer	0.000322	0.00243	CcSEcCtD
Fluconazole—Thrombocytopenia—Vincristine—colon cancer	0.000321	0.00242	CcSEcCtD
Fluconazole—Anaphylactic shock—Irinotecan—colon cancer	0.00032	0.00241	CcSEcCtD
Fluconazole—Myalgia—Fluorouracil—colon cancer	0.000319	0.00241	CcSEcCtD
Fluconazole—Hyperhidrosis—Vincristine—colon cancer	0.000317	0.00239	CcSEcCtD
Fluconazole—Hepatobiliary disease—Capecitabine—colon cancer	0.000317	0.00239	CcSEcCtD
Fluconazole—Discomfort—Fluorouracil—colon cancer	0.000316	0.00238	CcSEcCtD
Fluconazole—Nervous system disorder—Irinotecan—colon cancer	0.000314	0.00236	CcSEcCtD
Fluconazole—Agranulocytosis—Capecitabine—colon cancer	0.000313	0.00236	CcSEcCtD
Fluconazole—Thrombocytopenia—Irinotecan—colon cancer	0.000313	0.00236	CcSEcCtD
Fluconazole—Anorexia—Vincristine—colon cancer	0.000313	0.00236	CcSEcCtD
Fluconazole—Hyperhidrosis—Irinotecan—colon cancer	0.000309	0.00233	CcSEcCtD
Fluconazole—Anaphylactic shock—Fluorouracil—colon cancer	0.000306	0.00231	CcSEcCtD
Fluconazole—Anorexia—Irinotecan—colon cancer	0.000305	0.0023	CcSEcCtD
Fluconazole—Ataxia—Methotrexate—colon cancer	0.000305	0.0023	CcSEcCtD
Fluconazole—Nervous system disorder—Fluorouracil—colon cancer	0.0003	0.00226	CcSEcCtD
Fluconazole—Thrombocytopenia—Fluorouracil—colon cancer	0.0003	0.00226	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000299	0.00225	CcSEcCtD
Fluconazole—Pharyngitis—Capecitabine—colon cancer	0.000299	0.00225	CcSEcCtD
Fluconazole—Urinary tract disorder—Capecitabine—colon cancer	0.000297	0.00224	CcSEcCtD
Fluconazole—Insomnia—Vincristine—colon cancer	0.000297	0.00224	CcSEcCtD
Fluconazole—Connective tissue disorder—Capecitabine—colon cancer	0.000296	0.00223	CcSEcCtD
Fluconazole—Urethral disorder—Capecitabine—colon cancer	0.000295	0.00222	CcSEcCtD
Fluconazole—Paraesthesia—Vincristine—colon cancer	0.000295	0.00222	CcSEcCtD
Fluconazole—Breast disorder—Methotrexate—colon cancer	0.000293	0.00221	CcSEcCtD
Fluconazole—Anorexia—Fluorouracil—colon cancer	0.000292	0.0022	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000292	0.0022	CcSEcCtD
Fluconazole—Visual impairment—Capecitabine—colon cancer	0.00029	0.00219	CcSEcCtD
Fluconazole—Insomnia—Irinotecan—colon cancer	0.000289	0.00218	CcSEcCtD
Fluconazole—Paraesthesia—Irinotecan—colon cancer	0.000287	0.00216	CcSEcCtD
Fluconazole—Decreased appetite—Vincristine—colon cancer	0.000285	0.00215	CcSEcCtD
Fluconazole—Erythema multiforme—Capecitabine—colon cancer	0.000285	0.00215	CcSEcCtD
Fluconazole—Somnolence—Irinotecan—colon cancer	0.000284	0.00214	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Vincristine—colon cancer	0.000283	0.00214	CcSEcCtD
Fluconazole—Fatigue—Vincristine—colon cancer	0.000283	0.00213	CcSEcCtD
Fluconazole—Eye disorder—Capecitabine—colon cancer	0.000281	0.00212	CcSEcCtD
Fluconazole—Dyspepsia—Irinotecan—colon cancer	0.000281	0.00212	CcSEcCtD
Fluconazole—Pain—Vincristine—colon cancer	0.000281	0.00212	CcSEcCtD
Fluconazole—Constipation—Vincristine—colon cancer	0.000281	0.00212	CcSEcCtD
Fluconazole—Cardiac disorder—Capecitabine—colon cancer	0.00028	0.00211	CcSEcCtD
Fluconazole—Flushing—Capecitabine—colon cancer	0.00028	0.00211	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000279	0.0021	CcSEcCtD
Fluconazole—Decreased appetite—Irinotecan—colon cancer	0.000278	0.00209	CcSEcCtD
Fluconazole—Insomnia—Fluorouracil—colon cancer	0.000277	0.00209	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000276	0.00208	CcSEcCtD
Fluconazole—Fatigue—Irinotecan—colon cancer	0.000276	0.00208	CcSEcCtD
Fluconazole—Paraesthesia—Fluorouracil—colon cancer	0.000275	0.00207	CcSEcCtD
Fluconazole—Pain—Irinotecan—colon cancer	0.000273	0.00206	CcSEcCtD
Fluconazole—Constipation—Irinotecan—colon cancer	0.000273	0.00206	CcSEcCtD
Fluconazole—Angiopathy—Capecitabine—colon cancer	0.000273	0.00206	CcSEcCtD
Fluconazole—Somnolence—Fluorouracil—colon cancer	0.000272	0.00205	CcSEcCtD
Fluconazole—Immune system disorder—Capecitabine—colon cancer	0.000272	0.00205	CcSEcCtD
Fluconazole—Mediastinal disorder—Capecitabine—colon cancer	0.000271	0.00205	CcSEcCtD
Fluconazole—Chills—Capecitabine—colon cancer	0.00027	0.00204	CcSEcCtD
Fluconazole—Dyspepsia—Fluorouracil—colon cancer	0.00027	0.00203	CcSEcCtD
Fluconazole—Gastrointestinal pain—Vincristine—colon cancer	0.000268	0.00202	CcSEcCtD
Fluconazole—Decreased appetite—Fluorouracil—colon cancer	0.000266	0.00201	CcSEcCtD
Fluconazole—Alopecia—Capecitabine—colon cancer	0.000266	0.00201	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000264	0.00199	CcSEcCtD
Fluconazole—Mental disorder—Capecitabine—colon cancer	0.000264	0.00199	CcSEcCtD
Fluconazole—Feeling abnormal—Irinotecan—colon cancer	0.000263	0.00199	CcSEcCtD
Fluconazole—Malnutrition—Capecitabine—colon cancer	0.000262	0.00198	CcSEcCtD
Fluconazole—Neutropenia—Methotrexate—colon cancer	0.000262	0.00197	CcSEcCtD
Fluconazole—Pain—Fluorouracil—colon cancer	0.000262	0.00197	CcSEcCtD
Fluconazole—Gastrointestinal pain—Irinotecan—colon cancer	0.000261	0.00197	CcSEcCtD
Fluconazole—Body temperature increased—Vincristine—colon cancer	0.00026	0.00196	CcSEcCtD
Fluconazole—Abdominal pain—Vincristine—colon cancer	0.00026	0.00196	CcSEcCtD
Fluconazole—Flatulence—Capecitabine—colon cancer	0.000258	0.00195	CcSEcCtD
Fluconazole—Dysgeusia—Capecitabine—colon cancer	0.000257	0.00193	CcSEcCtD
Fluconazole—Back pain—Capecitabine—colon cancer	0.000254	0.00191	CcSEcCtD
Fluconazole—Abdominal pain—Irinotecan—colon cancer	0.000253	0.0019	CcSEcCtD
Fluconazole—Body temperature increased—Irinotecan—colon cancer	0.000253	0.0019	CcSEcCtD
Fluconazole—Feeling abnormal—Fluorouracil—colon cancer	0.000252	0.0019	CcSEcCtD
Fluconazole—Infestation NOS—Methotrexate—colon cancer	0.00025	0.00188	CcSEcCtD
Fluconazole—Infestation—Methotrexate—colon cancer	0.00025	0.00188	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000248	0.00187	CcSEcCtD
Fluconazole—Tremor—Capecitabine—colon cancer	0.000246	0.00185	CcSEcCtD
Fluconazole—Stomatitis—Methotrexate—colon cancer	0.000243	0.00183	CcSEcCtD
Fluconazole—Ill-defined disorder—Capecitabine—colon cancer	0.000243	0.00183	CcSEcCtD
Fluconazole—Urticaria—Fluorouracil—colon cancer	0.000243	0.00183	CcSEcCtD
Fluconazole—Anaemia—Capecitabine—colon cancer	0.000242	0.00183	CcSEcCtD
Fluconazole—Body temperature increased—Fluorouracil—colon cancer	0.000242	0.00182	CcSEcCtD
Fluconazole—Hypersensitivity—Vincristine—colon cancer	0.000242	0.00182	CcSEcCtD
Fluconazole—Malaise—Capecitabine—colon cancer	0.000236	0.00178	CcSEcCtD
Fluconazole—Hepatobiliary disease—Methotrexate—colon cancer	0.000236	0.00178	CcSEcCtD
Fluconazole—Vertigo—Capecitabine—colon cancer	0.000236	0.00177	CcSEcCtD
Fluconazole—Hypersensitivity—Irinotecan—colon cancer	0.000236	0.00177	CcSEcCtD
Fluconazole—Asthenia—Vincristine—colon cancer	0.000236	0.00177	CcSEcCtD
Fluconazole—Leukopenia—Capecitabine—colon cancer	0.000235	0.00177	CcSEcCtD
Fluconazole—Agranulocytosis—Methotrexate—colon cancer	0.000233	0.00176	CcSEcCtD
Fluconazole—Asthenia—Irinotecan—colon cancer	0.000229	0.00173	CcSEcCtD
Fluconazole—Hypertension—Capecitabine—colon cancer	0.000226	0.00171	CcSEcCtD
Fluconazole—Hypersensitivity—Fluorouracil—colon cancer	0.000226	0.0017	CcSEcCtD
Fluconazole—Diarrhoea—Vincristine—colon cancer	0.000225	0.00169	CcSEcCtD
Fluconazole—Myalgia—Capecitabine—colon cancer	0.000223	0.00168	CcSEcCtD
Fluconazole—Pharyngitis—Methotrexate—colon cancer	0.000223	0.00168	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000222	0.00167	CcSEcCtD
Fluconazole—Urinary tract disorder—Methotrexate—colon cancer	0.000221	0.00167	CcSEcCtD
Fluconazole—Discomfort—Capecitabine—colon cancer	0.000221	0.00166	CcSEcCtD
Fluconazole—Urethral disorder—Methotrexate—colon cancer	0.00022	0.00166	CcSEcCtD
Fluconazole—Diarrhoea—Irinotecan—colon cancer	0.000219	0.00165	CcSEcCtD
Fluconazole—Dry mouth—Capecitabine—colon cancer	0.000218	0.00164	CcSEcCtD
Fluconazole—Dizziness—Vincristine—colon cancer	0.000217	0.00164	CcSEcCtD
Fluconazole—Pruritus—Fluorouracil—colon cancer	0.000217	0.00163	CcSEcCtD
Fluconazole—Visual impairment—Methotrexate—colon cancer	0.000216	0.00163	CcSEcCtD
Fluconazole—Erythema multiforme—Methotrexate—colon cancer	0.000212	0.0016	CcSEcCtD
Fluconazole—Dizziness—Irinotecan—colon cancer	0.000211	0.00159	CcSEcCtD
Fluconazole—Nervous system disorder—Capecitabine—colon cancer	0.00021	0.00158	CcSEcCtD
Fluconazole—Eye disorder—Methotrexate—colon cancer	0.00021	0.00158	CcSEcCtD
Fluconazole—Diarrhoea—Fluorouracil—colon cancer	0.000209	0.00158	CcSEcCtD
Fluconazole—Thrombocytopenia—Capecitabine—colon cancer	0.000209	0.00158	CcSEcCtD
Fluconazole—Vomiting—Vincristine—colon cancer	0.000209	0.00157	CcSEcCtD
Fluconazole—Cardiac disorder—Methotrexate—colon cancer	0.000208	0.00157	CcSEcCtD
Fluconazole—Skin disorder—Capecitabine—colon cancer	0.000208	0.00157	CcSEcCtD
Fluconazole—Rash—Vincristine—colon cancer	0.000207	0.00156	CcSEcCtD
Fluconazole—Hyperhidrosis—Capecitabine—colon cancer	0.000207	0.00156	CcSEcCtD
Fluconazole—Dermatitis—Vincristine—colon cancer	0.000207	0.00156	CcSEcCtD
Fluconazole—Headache—Vincristine—colon cancer	0.000206	0.00155	CcSEcCtD
Fluconazole—Anorexia—Capecitabine—colon cancer	0.000204	0.00154	CcSEcCtD
Fluconazole—Angiopathy—Methotrexate—colon cancer	0.000203	0.00153	CcSEcCtD
Fluconazole—Vomiting—Irinotecan—colon cancer	0.000203	0.00153	CcSEcCtD
Fluconazole—Immune system disorder—Methotrexate—colon cancer	0.000203	0.00153	CcSEcCtD
Fluconazole—Dizziness—Fluorouracil—colon cancer	0.000202	0.00153	CcSEcCtD
Fluconazole—Mediastinal disorder—Methotrexate—colon cancer	0.000202	0.00152	CcSEcCtD
Fluconazole—Rash—Irinotecan—colon cancer	0.000202	0.00152	CcSEcCtD
Fluconazole—Dermatitis—Irinotecan—colon cancer	0.000201	0.00152	CcSEcCtD
Fluconazole—Chills—Methotrexate—colon cancer	0.000201	0.00152	CcSEcCtD
Fluconazole—Headache—Irinotecan—colon cancer	0.0002	0.00151	CcSEcCtD
Fluconazole—Alopecia—Methotrexate—colon cancer	0.000198	0.00149	CcSEcCtD
Fluconazole—Mental disorder—Methotrexate—colon cancer	0.000196	0.00148	CcSEcCtD
Fluconazole—Malnutrition—Methotrexate—colon cancer	0.000195	0.00147	CcSEcCtD
Fluconazole—Nausea—Vincristine—colon cancer	0.000195	0.00147	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000195	0.00147	CcSEcCtD
Fluconazole—Vomiting—Fluorouracil—colon cancer	0.000195	0.00147	CcSEcCtD
Fluconazole—Insomnia—Capecitabine—colon cancer	0.000194	0.00146	CcSEcCtD
Fluconazole—Rash—Fluorouracil—colon cancer	0.000193	0.00145	CcSEcCtD
Fluconazole—Dermatitis—Fluorouracil—colon cancer	0.000193	0.00145	CcSEcCtD
Fluconazole—Paraesthesia—Capecitabine—colon cancer	0.000192	0.00145	CcSEcCtD
Fluconazole—Headache—Fluorouracil—colon cancer	0.000192	0.00145	CcSEcCtD
Fluconazole—Dysgeusia—Methotrexate—colon cancer	0.000191	0.00144	CcSEcCtD
Fluconazole—Nausea—Irinotecan—colon cancer	0.00019	0.00143	CcSEcCtD
Fluconazole—Back pain—Methotrexate—colon cancer	0.000189	0.00142	CcSEcCtD
Fluconazole—Dyspepsia—Capecitabine—colon cancer	0.000188	0.00142	CcSEcCtD
Fluconazole—Decreased appetite—Capecitabine—colon cancer	0.000186	0.0014	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000185	0.00139	CcSEcCtD
Fluconazole—Fatigue—Capecitabine—colon cancer	0.000184	0.00139	CcSEcCtD
Fluconazole—Pain—Capecitabine—colon cancer	0.000183	0.00138	CcSEcCtD
Fluconazole—Constipation—Capecitabine—colon cancer	0.000183	0.00138	CcSEcCtD
Fluconazole—Nausea—Fluorouracil—colon cancer	0.000182	0.00137	CcSEcCtD
Fluconazole—Ill-defined disorder—Methotrexate—colon cancer	0.000181	0.00136	CcSEcCtD
Fluconazole—Anaemia—Methotrexate—colon cancer	0.00018	0.00136	CcSEcCtD
Fluconazole—Feeling abnormal—Capecitabine—colon cancer	0.000176	0.00133	CcSEcCtD
Fluconazole—Malaise—Methotrexate—colon cancer	0.000176	0.00133	CcSEcCtD
Fluconazole—Vertigo—Methotrexate—colon cancer	0.000175	0.00132	CcSEcCtD
Fluconazole—Gastrointestinal pain—Capecitabine—colon cancer	0.000175	0.00132	CcSEcCtD
Fluconazole—Leukopenia—Methotrexate—colon cancer	0.000175	0.00132	CcSEcCtD
Fluconazole—Urticaria—Capecitabine—colon cancer	0.00017	0.00128	CcSEcCtD
Fluconazole—Abdominal pain—Capecitabine—colon cancer	0.000169	0.00127	CcSEcCtD
Fluconazole—Body temperature increased—Capecitabine—colon cancer	0.000169	0.00127	CcSEcCtD
Fluconazole—Convulsion—Methotrexate—colon cancer	0.000169	0.00127	CcSEcCtD
Fluconazole—Myalgia—Methotrexate—colon cancer	0.000166	0.00125	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000165	0.00124	CcSEcCtD
Fluconazole—Discomfort—Methotrexate—colon cancer	0.000164	0.00124	CcSEcCtD
Fluconazole—Anaphylactic shock—Methotrexate—colon cancer	0.000159	0.0012	CcSEcCtD
Fluconazole—Hypersensitivity—Capecitabine—colon cancer	0.000158	0.00119	CcSEcCtD
Fluconazole—Nervous system disorder—Methotrexate—colon cancer	0.000156	0.00118	CcSEcCtD
Fluconazole—Thrombocytopenia—Methotrexate—colon cancer	0.000156	0.00118	CcSEcCtD
Fluconazole—Skin disorder—Methotrexate—colon cancer	0.000155	0.00117	CcSEcCtD
Fluconazole—Hyperhidrosis—Methotrexate—colon cancer	0.000154	0.00116	CcSEcCtD
Fluconazole—Asthenia—Capecitabine—colon cancer	0.000154	0.00116	CcSEcCtD
Fluconazole—Anorexia—Methotrexate—colon cancer	0.000152	0.00114	CcSEcCtD
Fluconazole—Pruritus—Capecitabine—colon cancer	0.000151	0.00114	CcSEcCtD
Fluconazole—Diarrhoea—Capecitabine—colon cancer	0.000146	0.0011	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000145	0.00109	CcSEcCtD
Fluconazole—Insomnia—Methotrexate—colon cancer	0.000144	0.00109	CcSEcCtD
Fluconazole—Paraesthesia—Methotrexate—colon cancer	0.000143	0.00108	CcSEcCtD
Fluconazole—Somnolence—Methotrexate—colon cancer	0.000142	0.00107	CcSEcCtD
Fluconazole—Dizziness—Capecitabine—colon cancer	0.000141	0.00107	CcSEcCtD
Fluconazole—Dyspepsia—Methotrexate—colon cancer	0.00014	0.00106	CcSEcCtD
Fluconazole—Decreased appetite—Methotrexate—colon cancer	0.000138	0.00104	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Methotrexate—colon cancer	0.000138	0.00104	CcSEcCtD
Fluconazole—Fatigue—Methotrexate—colon cancer	0.000137	0.00103	CcSEcCtD
Fluconazole—Pain—Methotrexate—colon cancer	0.000136	0.00103	CcSEcCtD
Fluconazole—Vomiting—Capecitabine—colon cancer	0.000136	0.00103	CcSEcCtD
Fluconazole—Rash—Capecitabine—colon cancer	0.000135	0.00102	CcSEcCtD
Fluconazole—Dermatitis—Capecitabine—colon cancer	0.000135	0.00102	CcSEcCtD
Fluconazole—Headache—Capecitabine—colon cancer	0.000134	0.00101	CcSEcCtD
Fluconazole—Feeling abnormal—Methotrexate—colon cancer	0.000131	0.000989	CcSEcCtD
Fluconazole—Gastrointestinal pain—Methotrexate—colon cancer	0.00013	0.000982	CcSEcCtD
Fluconazole—Nausea—Capecitabine—colon cancer	0.000127	0.000958	CcSEcCtD
Fluconazole—Urticaria—Methotrexate—colon cancer	0.000127	0.000954	CcSEcCtD
Fluconazole—Abdominal pain—Methotrexate—colon cancer	0.000126	0.000949	CcSEcCtD
Fluconazole—Body temperature increased—Methotrexate—colon cancer	0.000126	0.000949	CcSEcCtD
Fluconazole—Hypersensitivity—Methotrexate—colon cancer	0.000117	0.000884	CcSEcCtD
Fluconazole—Asthenia—Methotrexate—colon cancer	0.000114	0.000861	CcSEcCtD
Fluconazole—Pruritus—Methotrexate—colon cancer	0.000113	0.000849	CcSEcCtD
Fluconazole—Diarrhoea—Methotrexate—colon cancer	0.000109	0.000821	CcSEcCtD
Fluconazole—Dizziness—Methotrexate—colon cancer	0.000105	0.000794	CcSEcCtD
Fluconazole—Vomiting—Methotrexate—colon cancer	0.000101	0.000763	CcSEcCtD
Fluconazole—Rash—Methotrexate—colon cancer	0.0001	0.000757	CcSEcCtD
Fluconazole—Dermatitis—Methotrexate—colon cancer	0.0001	0.000756	CcSEcCtD
Fluconazole—Headache—Methotrexate—colon cancer	9.98e-05	0.000752	CcSEcCtD
Fluconazole—Nausea—Methotrexate—colon cancer	9.46e-05	0.000713	CcSEcCtD
